Literature DB >> 23063976

Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.

Christopher Chiaro1, Darina L Lazarova, Michael Bordonaro.   

Abstract

Butyrate, a fermentation product of dietary fiber, inhibits clonal growth in colorectal cancer (CRC) cells dependent upon the fold induction of Wnt activity. We have developed a CRC cell line (HCT-R) that, unlike its parental cell line, HCT-116, does not respond to butyrate exposure with hyperactivation of Wnt signaling and suppressed clonal growth. PCR array analyses revealed Wnt pathway-related genes, the expression of which differs between butyrate-sensitive HCT-116 CRC cells and their butyrate-resistant HCT-R cell counterparts. We identified overexpression of Tcf3 as being partially responsible for the butyrate-resistant phenotype, as this DNA-binding protein suppresses the hyperinduction of Wnt activity by butyrate. Consequently, Tcf3 knockdown in HCT-R cells restores their sensitivity to the effects of butyrate on Wnt activity and clonal cell growth. Interestingly, the effects of overexpressed Tcf3 differ between HCT-116 and HCT-R cells; thus, in HCT-116 cells Tcf3 suppresses proliferation without rendering the cells resistant to butyrate. In HCT-R cells, however, the overexpression of Tcf3 inhibits Wnt activity, and the cells are still able to proliferate due to the higher expression levels of cell cycle factors, particularly those driving the G(1) to S transition. Knowledge of the molecular mechanisms determining the variable sensitivity of CRC cells to butyrate may assist in developing approaches that prevent or reverse butyrate resistance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063976     DOI: 10.1016/j.bbrc.2012.10.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.

Authors:  Meera Shah; Sherri A Rennoll; Wesley M Raup-Konsavage; Gregory S Yochum
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  TCF3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma.

Authors:  Wei Zeng; Haixiao Jiang; Ying Wang; Cunzu Wang; Bo Yu
Journal:  Neurotox Res       Date:  2022-04-21       Impact factor: 3.911

Review 3.  CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.

Authors:  Michael Bordonaro; Darina L Lazarova
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

4.  PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.

Authors:  G Zhu; X Li; B Guo; Q Ke; M Dong; F Li
Journal:  Oncogene       Date:  2015-07-27       Impact factor: 9.867

Review 5.  Colorectal carcinogenesis: a cellular response to sustained risk environment.

Authors:  Kim Y C Fung; Cheng Cheng Ooi; Michelle H Zucker; Trevor Lockett; Desmond B Williams; Leah J Cosgrove; David L Topping
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

6.  p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.

Authors:  Darina L Lazarova; Terrence Wong; Christopher Chiaro; Eric Drago; Michael Bordonaro
Journal:  J Cancer       Date:  2013-07-18       Impact factor: 4.207

7.  Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.

Authors:  Darina Lazarova; Andrew Lee; Terrence Wong; Brigitte Marian; Christopher Chiaro; Christian Rainey; Michael Bordonaro
Journal:  J Cancer       Date:  2014-02-14       Impact factor: 4.207

8.  ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.

Authors:  Darina Lazarova; Michael Bordonaro
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

9.  Targeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients.

Authors:  Jiaofang Shao; Xiaoyan Lou; Jun Wang; Jing Zhang; Chen Chen; Dasong Hua; Fan Mo; Xu Han; Shu Zheng; Biaoyang Lin
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 10.  Vimentin, colon cancer progression and resistance to butyrate and other HDACis.

Authors:  Darina L Lazarova; Michael Bordonaro
Journal:  J Cell Mol Med       Date:  2016-04-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.